Global Radiofrequency Ablation for Pain Management Market Growth (Status and Outlook) 2023-2029

Global Radiofrequency Ablation for Pain Management Market Growth (Status and Outlook) 2023-2029

A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints.
Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or "burn," the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain.
This procedure is most commonly used to treat chronic pain and conditions such as arthritis of the spine (spondylosis) and sacroilitis. It is also used to treat neck, back, knee, pelvic and peripheral nerve pain. The benefits of radiofrequency ablation include avoiding surgery, immediate pain relief, little to no recovery time, decreased need for pain medication, improved function, and a quicker return to work and other activities.
LPI (LP Information)' newest research report, the “Radiofrequency Ablation for Pain Management Industry Forecast” looks at past sales and reviews total world Radiofrequency Ablation for Pain Management sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiofrequency Ablation for Pain Management sales for 2023 through 2029. With Radiofrequency Ablation for Pain Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiofrequency Ablation for Pain Management industry.
This Insight Report provides a comprehensive analysis of the global Radiofrequency Ablation for Pain Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiofrequency Ablation for Pain Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiofrequency Ablation for Pain Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiofrequency Ablation for Pain Management and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiofrequency Ablation for Pain Management.
The global Radiofrequency Ablation for Pain Management market size is projected to grow from US$ 268.9 million in 2022 to US$ 536.6 million in 2029; it is expected to grow at a CAGR of 10.4% from 2023 to 2029.
A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints.Based on product type, the radiofrequency ablation for pain management market has been segmented into RF generators, reusable (probes, electrodes), and disposable (cannula, needles, single-use probes, and single-use electrodes). Of these, the segment of disposable products, accounted for over 43.9% of the global market in 2019.Radiofrequency Ablation for Pain Management is widely sold in Hospital, Clinic. The most proportion of Radiofrequency Ablation for Pain Management is sold in Hospital, and the proportion in 2019 is 66.9%.
North America is the largest Sales place, with a Sales market share nearly 48.3% in 2019. Following North America, Europe is the second largest Sales place with the Sales market share of 24.2%.
Market competition is intense. Abbott (St. Jude Medical), Avanos Medical, Stryker, Boston Scientific, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiofrequency Ablation for Pain Management market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
RF Generators
Reusable Products
Disposable Products
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott (St. Jude Medical)
Avanos Medical
Stryker
Boston Scientific
Medtronic
Diros Technology

Please note: The report will take approximately 2 business days to prepare and deliver.